Skip to main content
Top
Published in: BMC Psychiatry 1/2016

Open Access 01-12-2016 | Research article

Characteristics of individuals presenting to treatment for primary alcohol problems versus other drug problems in the Australian patient pathways study

Authors: Dan I. Lubman, Joshua B. B. Garfield, Victoria Manning, Lynda Berends, David Best, Janette M. Mugavin, Tina Lam, Penny Buykx, Andrew Larner, Belinda Lloyd, Robin Room, Steve Allsop

Published in: BMC Psychiatry | Issue 1/2016

Login to get access

Abstract

Background

People seeking treatment for substance use disorders often have additional health and social issues. Although individuals presenting with alcohol as the primary drug of concern (PDOC) account for nearly half of all treatment episodes to the Australian alcohol and other drug (AOD) service system, previous treatment cohort studies have focused only on the profile of Australian heroin or methamphetamine users. While studies overseas indicate that clients seeking treatment primarily for their drinking are less likely to experience social and economic marginalisation than those seeking treatment primarily for illicit or pharmaceutical drug use, very little research has directly compared individuals presenting with alcohol as the PDOC to those primarily presenting with other drugs as their PDOC.

Methods

Seven hundred and ninety-six participants were recruited at entry to specialist AOD treatment in Victoria and Western Australia, and completed measures of demographic and social factors, substance use, quality of life, service use, and criminal justice involvement. We compared those with alcohol as their PDOC to those with other drugs as their PDOC using Pearson chi-square and Mann–Whitney U tests.

Results

Rates of social disadvantage, poor quality of life, high severity of substance dependence, and past-year AOD, mental health, acute health, and social service use were high in all groups. However, participants with alcohol as the PDOC were older; more likely to have an educational qualification; less likely to report criminal justice involvement, housing/homelessness service use, tobacco smoking, or problems with multiple substances; and reported better environmental quality of life; but were more likely to have used ambulance services, than those with other drugs as their PDOC.

Conclusions

While those seeking treatment primarily for alcohol problems appear less likely to suffer some forms of social and economic disadvantage or to use multiple substances than those with a primary drug problem, they experience similarly high levels of substance dependence severity and mental health and AOD service use. These findings reinforce the need for AOD services to integrate or coordinate care with programs that address the many complexities clients frequently present with, while also acknowledging differences between those seeking treatment for alcohol versus other drug problems.
Literature
1.
go back to reference AIHW. Drugs in Australia 2010: tobacco, alcohol, and other drugs. Canberra: Australian Institute of Health and Welfare; 2011. AIHW. Drugs in Australia 2010: tobacco, alcohol, and other drugs. Canberra: Australian Institute of Health and Welfare; 2011.
2.
go back to reference Babor TF, Caetano R, Casswell S, Edwards G, Giesbrecht N, Graham K, Grube JW, Hill L, Holder H, Homel R, et al. Alcohol: No ordinary commodity: research and public policy. 2nd ed. Oxford: Oxford University Press; 2010.CrossRef Babor TF, Caetano R, Casswell S, Edwards G, Giesbrecht N, Graham K, Grube JW, Hill L, Holder H, Homel R, et al. Alcohol: No ordinary commodity: research and public policy. 2nd ed. Oxford: Oxford University Press; 2010.CrossRef
3.
go back to reference Collins DJ, Lapsley HM. The costs of tobacco, alcohol and illicit drug abuse to Australian society in 2004/05. In. Canberra: Commonwealth of Australia; 2008. Collins DJ, Lapsley HM. The costs of tobacco, alcohol and illicit drug abuse to Australian society in 2004/05. In. Canberra: Commonwealth of Australia; 2008.
4.
go back to reference WHO. Global health risks: mortality and burden of disease attributable to selected major risks. Geneva: World Health Organization Press; 2009. WHO. Global health risks: mortality and burden of disease attributable to selected major risks. Geneva: World Health Organization Press; 2009.
5.
go back to reference Teesson M, Hall W, Slade T, Mills K, Grove R, Mewton L, Baillie A, Haber P. Prevalence and correlates of DSM-IV alcohol abuse and dependence in Australia: findings of the 2007 national survey of mental health and wellbeing. Addiction. 2010;105(12):2085–94.CrossRefPubMed Teesson M, Hall W, Slade T, Mills K, Grove R, Mewton L, Baillie A, Haber P. Prevalence and correlates of DSM-IV alcohol abuse and dependence in Australia: findings of the 2007 national survey of mental health and wellbeing. Addiction. 2010;105(12):2085–94.CrossRefPubMed
6.
go back to reference Reavley NJ, Cvetkovski S, Jorm AF, Lubman DI. Help-seeking for substance use, anxiety and affective disorders among young people: results from the 2007 Australian National Survey of Mental Health and Wellbeing. Aust N Z J Psychiatry. 2010;44(8):729–35.CrossRefPubMed Reavley NJ, Cvetkovski S, Jorm AF, Lubman DI. Help-seeking for substance use, anxiety and affective disorders among young people: results from the 2007 Australian National Survey of Mental Health and Wellbeing. Aust N Z J Psychiatry. 2010;44(8):729–35.CrossRefPubMed
7.
8.
go back to reference Gossop M, Marsden J, Stewart D, Lehmann P, Edwards C, Wilson A, Segar G. Substance use, health and social problems of service users at 54 drug treatment agencies. Intake data from the National Treatment Outcome Research Study. Br J Psychiatry. 1998;173:166–71.CrossRefPubMed Gossop M, Marsden J, Stewart D, Lehmann P, Edwards C, Wilson A, Segar G. Substance use, health and social problems of service users at 54 drug treatment agencies. Intake data from the National Treatment Outcome Research Study. Br J Psychiatry. 1998;173:166–71.CrossRefPubMed
9.
go back to reference Laudet AB, Stanick V, Sands B. What could the program have done differently? A qualitative examination of reasons for leaving outpatient treatment. J Subst Abus Treat. 2009;37(2):182–90.CrossRef Laudet AB, Stanick V, Sands B. What could the program have done differently? A qualitative examination of reasons for leaving outpatient treatment. J Subst Abus Treat. 2009;37(2):182–90.CrossRef
10.
go back to reference Marsden J, Gossop M, Stewart D, Rolfe A, Farrell M. Psychiatric symptoms among clients seeking treatment for drug dependence. Intake data from the National Treatment Outcome Research Study. Br J Psychiatry. 2000;176:285–9.CrossRefPubMed Marsden J, Gossop M, Stewart D, Rolfe A, Farrell M. Psychiatric symptoms among clients seeking treatment for drug dependence. Intake data from the National Treatment Outcome Research Study. Br J Psychiatry. 2000;176:285–9.CrossRefPubMed
11.
go back to reference McKetin R, Lubman DI, Lee NM, Ross JE, Slade TN. Major depression among methamphetamine users entering drug treatment programs. Med J Aust. 2011;195(3):S51–55.PubMed McKetin R, Lubman DI, Lee NM, Ross JE, Slade TN. Major depression among methamphetamine users entering drug treatment programs. Med J Aust. 2011;195(3):S51–55.PubMed
12.
go back to reference Ross J, Teesson M, Darke S, Lynskey M, Ali R, Ritter A, Cooke R. The characteristics of heroin users entering treatment: findings from the Australian treatment outcome study (ATOS). Drug Alcohol Rev. 2005;24(5):411–8.CrossRefPubMed Ross J, Teesson M, Darke S, Lynskey M, Ali R, Ritter A, Cooke R. The characteristics of heroin users entering treatment: findings from the Australian treatment outcome study (ATOS). Drug Alcohol Rev. 2005;24(5):411–8.CrossRefPubMed
13.
go back to reference Storbjörk J, Room R. The two worlds of alcohol problems: Who is in treatment and who is not? Addict Res Theory. 2008;16(1):67–84.CrossRef Storbjörk J, Room R. The two worlds of alcohol problems: Who is in treatment and who is not? Addict Res Theory. 2008;16(1):67–84.CrossRef
14.
go back to reference Manning V, Gomez B, Guo S, Low YD, Koh PK, Wong KE. An exploration of quality of life and its predictors in patients with addictive disorders: Gambling, alcohol and drugs. Int J Ment Heal Addict. 2012;10(4):551–62.CrossRef Manning V, Gomez B, Guo S, Low YD, Koh PK, Wong KE. An exploration of quality of life and its predictors in patients with addictive disorders: Gambling, alcohol and drugs. Int J Ment Heal Addict. 2012;10(4):551–62.CrossRef
15.
go back to reference Stenius K, Witbrodt J, Engdahl B, Weisner C. For the marginalized or for the integrated? A comparative study of addiction treatment systems in Sweden and the United States. Contemporary Drug Problems. 2010;37(3):417–48.CrossRef Stenius K, Witbrodt J, Engdahl B, Weisner C. For the marginalized or for the integrated? A comparative study of addiction treatment systems in Sweden and the United States. Contemporary Drug Problems. 2010;37(3):417–48.CrossRef
16.
go back to reference Lloyd B, Barratt MJ, Ferris J, Best D, Lubman DI. Factors influencing mortality among alcohol and drug treatment clients in Victoria, Australia: the role of demographic and substance use characteristics. Aust N Z J Psychiatry. 2013;47(9):859–67.CrossRefPubMed Lloyd B, Barratt MJ, Ferris J, Best D, Lubman DI. Factors influencing mortality among alcohol and drug treatment clients in Victoria, Australia: the role of demographic and substance use characteristics. Aust N Z J Psychiatry. 2013;47(9):859–67.CrossRefPubMed
17.
go back to reference Public Health England. Adult substance misuse statistics from the National Drug Treatment Monitoring System (NDTMS): 1 April 2014 to 31 March 2015. London: Public Health England; 2015. Public Health England. Adult substance misuse statistics from the National Drug Treatment Monitoring System (NDTMS): 1 April 2014 to 31 March 2015. London: Public Health England; 2015.
18.
go back to reference AIHW. Alcohol and other drug treatment services in Australia 2012–13. Canberra: Australian Institute of Health and Welfare; 2014. AIHW. Alcohol and other drug treatment services in Australia 2012–13. Canberra: Australian Institute of Health and Welfare; 2014.
19.
go back to reference McKetin R, Najman JM, Baker AL, Lubman DI, Dawe S, Ali R, Lee NK, Mattick RP, Mamun A. Evaluating the impact of community-based treatment options on methamphetamine use: findings from the Methamphetamine Treatment Evaluation Study (MATES). Addiction. 2012;107(11):1998–2008.CrossRefPubMed McKetin R, Najman JM, Baker AL, Lubman DI, Dawe S, Ali R, Lee NK, Mattick RP, Mamun A. Evaluating the impact of community-based treatment options on methamphetamine use: findings from the Methamphetamine Treatment Evaluation Study (MATES). Addiction. 2012;107(11):1998–2008.CrossRefPubMed
20.
go back to reference Hawkins EJ, Malte CA, Baer JS, Kivlahan DR. Prevalence, predictors, and service utilization of patients with recurrent use of Veterans Affairs substance use disorder specialty care. J Subst Abus Treat. 2012;43(2):221–30.CrossRef Hawkins EJ, Malte CA, Baer JS, Kivlahan DR. Prevalence, predictors, and service utilization of patients with recurrent use of Veterans Affairs substance use disorder specialty care. J Subst Abus Treat. 2012;43(2):221–30.CrossRef
21.
go back to reference Parthasarathy S, Weisner CM. Five-year trajectories of health care utilization and cost in a drug and alcohol treatment sample. Drug Alcohol Depend. 2005;80(2):231–40.CrossRefPubMed Parthasarathy S, Weisner CM. Five-year trajectories of health care utilization and cost in a drug and alcohol treatment sample. Drug Alcohol Depend. 2005;80(2):231–40.CrossRefPubMed
22.
go back to reference Gossop M, Darke S, Griffiths P, Hando J, Powis B, Hall W, Strang J. The severity of dependence scale (SDS): psychometric properties of the SDS in English and Australian samples of heroin, cocaine and amphetamine users. Addiction. 1995;90(5):607–14.CrossRefPubMed Gossop M, Darke S, Griffiths P, Hando J, Powis B, Hall W, Strang J. The severity of dependence scale (SDS): psychometric properties of the SDS in English and Australian samples of heroin, cocaine and amphetamine users. Addiction. 1995;90(5):607–14.CrossRefPubMed
23.
go back to reference Skevington SM, Lotfy M, O’Connell KA. The World Health Organization’s WHOQOL-BREF quality of life assessment: psychometric properties and results of the international field trial. A report from the WHOQOL group. Qual Life Res. 2004;13(2):299–310.CrossRefPubMed Skevington SM, Lotfy M, O’Connell KA. The World Health Organization’s WHOQOL-BREF quality of life assessment: psychometric properties and results of the international field trial. A report from the WHOQOL group. Qual Life Res. 2004;13(2):299–310.CrossRefPubMed
24.
go back to reference Day E, Best D, Cantillano V, Gaston RL, Nambamali A, Keaney F. Measuring the use and career histories of drug users in treatment: reliability of the Lifetime Drug Use History (LDUH) and its data yield relative to clinical case notes. Drug Alcohol Rev. 2008;27(2):171–7.CrossRefPubMed Day E, Best D, Cantillano V, Gaston RL, Nambamali A, Keaney F. Measuring the use and career histories of drug users in treatment: reliability of the Lifetime Drug Use History (LDUH) and its data yield relative to clinical case notes. Drug Alcohol Rev. 2008;27(2):171–7.CrossRefPubMed
25.
go back to reference AIHW. Alcohol and other drug treatment services in Australia 2011–12. Canberra: Australian Institute of Health and Welfare; 2013. AIHW. Alcohol and other drug treatment services in Australia 2011–12. Canberra: Australian Institute of Health and Welfare; 2013.
26.
go back to reference ABS. Australian Social Trends September 2012: Education differences between men and women. Sydney: Australian Bureau of Statistics; 2012. ABS. Australian Social Trends September 2012: Education differences between men and women. Sydney: Australian Bureau of Statistics; 2012.
27.
go back to reference Hawthorne G, Herrman H, Murphy B. Interpreting the WHOQOL-BREF: Preliminary population norms and effect sizes. Soc Indic Res. 2006;77(1):37–59.CrossRef Hawthorne G, Herrman H, Murphy B. Interpreting the WHOQOL-BREF: Preliminary population norms and effect sizes. Soc Indic Res. 2006;77(1):37–59.CrossRef
28.
go back to reference Gossop M, Griffiths P, Powis B, Williamson S, Strang J. Frequency of non-fatal heroin overdose: survey of heroin users recruited in non-clinical settings. BMJ. 1996;313(7054):402.CrossRefPubMedPubMedCentral Gossop M, Griffiths P, Powis B, Williamson S, Strang J. Frequency of non-fatal heroin overdose: survey of heroin users recruited in non-clinical settings. BMJ. 1996;313(7054):402.CrossRefPubMedPubMedCentral
29.
go back to reference Darke S, Ross J, Teesson M, Lynskey M. Health service utilization and benzodiazepine use among heroin users: findings from the Australian Treatment Outcome Study (ATOS). Addiction. 2003;98(8):1129–35.CrossRefPubMed Darke S, Ross J, Teesson M, Lynskey M. Health service utilization and benzodiazepine use among heroin users: findings from the Australian Treatment Outcome Study (ATOS). Addiction. 2003;98(8):1129–35.CrossRefPubMed
30.
go back to reference Bachelard M, Gilmore H. Three drinks and you’re out. In: The Sydney Morning Herald. June 15, 2008 edn. Sydney; 2008. Bachelard M, Gilmore H. Three drinks and you’re out. In: The Sydney Morning Herald. June 15, 2008 edn. Sydney; 2008.
31.
go back to reference Maggs JL, Schulenberg JE. Trajectories of alcohol use during the transition to adulthood. Alcohol Res Health. 2004;28(4):195–201. Maggs JL, Schulenberg JE. Trajectories of alcohol use during the transition to adulthood. Alcohol Res Health. 2004;28(4):195–201.
32.
go back to reference Hall W, Room R, Bondy S. Comparing the health and psychological effects of alcohol, cannabis, nicotine and opiate use. In: Kalant H, Corrigall W, Hall W, Smart R, editors. The Health Effects of Cannabis. Toronto: Addiction Research Foundation Division, Centre for Addiction and Mental Health; 1999. p. 475–506. Hall W, Room R, Bondy S. Comparing the health and psychological effects of alcohol, cannabis, nicotine and opiate use. In: Kalant H, Corrigall W, Hall W, Smart R, editors. The Health Effects of Cannabis. Toronto: Addiction Research Foundation Division, Centre for Addiction and Mental Health; 1999. p. 475–506.
33.
go back to reference Lachenmeier DW, Rehm J. Comparative risk assessment of alcohol, tobacco, cannabis and other illicit drugs using the margin of exposure approach. Sci Rep. 2015;5:8126.CrossRefPubMedPubMedCentral Lachenmeier DW, Rehm J. Comparative risk assessment of alcohol, tobacco, cannabis and other illicit drugs using the margin of exposure approach. Sci Rep. 2015;5:8126.CrossRefPubMedPubMedCentral
34.
go back to reference Lee SJ, Crowther E, Keating C, Kulkarni J. What is needed to deliver collaborative care to address comorbidity more effectively for adults with a severe mental illness? Aust N Z J Psychiatry. 2013;47(4):333–46.CrossRefPubMed Lee SJ, Crowther E, Keating C, Kulkarni J. What is needed to deliver collaborative care to address comorbidity more effectively for adults with a severe mental illness? Aust N Z J Psychiatry. 2013;47(4):333–46.CrossRefPubMed
35.
go back to reference Sword W, Niccols A, Yousefi-Nooraie R, Dobbins M, Lipman E, Smith P. Partnerships among Canadian agencies serving women with substance abuse issues and their children. Int J Ment Health Addict. 2013;11(3):344–57.CrossRefPubMedPubMedCentral Sword W, Niccols A, Yousefi-Nooraie R, Dobbins M, Lipman E, Smith P. Partnerships among Canadian agencies serving women with substance abuse issues and their children. Int J Ment Health Addict. 2013;11(3):344–57.CrossRefPubMedPubMedCentral
Metadata
Title
Characteristics of individuals presenting to treatment for primary alcohol problems versus other drug problems in the Australian patient pathways study
Authors
Dan I. Lubman
Joshua B. B. Garfield
Victoria Manning
Lynda Berends
David Best
Janette M. Mugavin
Tina Lam
Penny Buykx
Andrew Larner
Belinda Lloyd
Robin Room
Steve Allsop
Publication date
01-12-2016
Publisher
BioMed Central
Published in
BMC Psychiatry / Issue 1/2016
Electronic ISSN: 1471-244X
DOI
https://doi.org/10.1186/s12888-016-0956-9

Other articles of this Issue 1/2016

BMC Psychiatry 1/2016 Go to the issue